GlassScriptIntact Vascular, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$203Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
185clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Peter Schneider | Honolulu, HI | Vascular Surgery | $74,051.92 |
| William Gray | Wynnewood, PA | Interventional Cardiology | $24,072.13 |
| David Deaton | Columbia, SC | Vascular Surgery | $23,549.31 |
| Ehrin Armstrong | Englewood, CO | Interventional Cardiology | $18,817.75 |
| Sarang Mangalmurti | Bryn Mawr, PA | Cardiovascular Disease | $9,704.83 |
| George Adams | Garner, NC | Interventional Cardiology | $9,004.37 |
| Nicolas Shammas | Davenport, IA | Interventional Cardiology | $8,500.75 |
| Thomas Davis | St Clair Shores, MI | Cardiovascular Disease | $8,300.74 |
| Bret Wiechmann | Gainesville, FL | Vascular & Interventional Radiology | $2,827.00 |
| Santhosh Mathews | Bradenton, FL | Interventional Cardiology | $2,509.11 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.